| First Author | Minotti R | Year | 2015 |
| Journal | Mol Cell Biol | Volume | 35 |
| Issue | 18 | Pages | 3189-99 |
| PubMed ID | 26149390 | Mgi Jnum | J:228232 |
| Mgi Id | MGI:5705694 | Doi | 10.1128/MCB.00196-15 |
| Citation | Minotti R, et al. (2015) ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation. Mol Cell Biol 35(18):3189-99 |
| abstractText | ADP-ribosyltransferase diphtheria-toxin like 1/poly(ADP-ribose) polymerase 1 (ARTD1/PARP1) is a chromatin-associated protein in the nucleus and plays an important role in different cellular processes such as regulation of gene transcription. ARTD1 has been shown to coregulate the inflammatory response by modulating the activity of the transcription factor nuclear factor kappaB (NF-kappaB), the principal regulator of interleukin 6 (IL-6), an important inflammatory cytokine implicated in a variety of diseases such as cancer. However, to what extent and how ARTD1 regulates IL-6 transcription has not been clear. Here, we show that ARTD1 suppresses lipopolysaccharide (LPS)-induced IL-6 expression in macrophages, without affecting the recruitment of the NF-kappaB subunit RelA to the IL-6 promoter and independent of its enzymatic activity. Interestingly, knockdown of ARTD1 did not alter H3 occupancy but increased LPS-induced trimethylation of histone 3 at lysine 4 (H3K4me3), a hallmark of transcriptionally active genes. We found that ARTD1 mediates its effect through the methyltransferase MLL1, by catalyzing H3K4me3 at the IL-6 promoter and forming a complex with NF-kappaB. These results demonstrate that ARTD1 modulates IL-6 expression by regulating the function of an NF-kappaB enhanceosome complex, which involves MLL1 and does not require ADP-ribosylation. |
